Caspase inhibition reduces apoptosis and increases survival of nigral transplants

Caspase inhibition reduces apoptosis and increases survival of nigral transplants

Play all audios:

Loading...

ABSTRACT TRANSPLANTATION OF EMBRYONIC NIGRAL TISSUE AMELIORATES FUNCTIONAL DEFICIENCIES IN PARKINSON DISEASE1,2. THE MAIN PRACTICAL CONSTRAINTS OF NEURAL GRAFTING ARE THE SHORTAGE OF HUMAN


DONOR TISSUE AND THE POOR SURVIVAL OF DOPAMINERGIC NEURONS GRAFTED INTO PATIENTS, WHICH IS ESTIMATED AT 5–10% (REFS. 3,4 ). THE REQUIRED AMOUNT OF HUMAN TISSUE COULD BE CONSIDERABLY REDUCED


IF THE NEURONAL SURVIVAL WAS AUGMENTED. STUDIES IN RATS INDICATE THAT MOST IMPLANTED EMBRYONIC NEURONS DIE WITHIN 1 WEEK OF TRANSPLANTATION5,6, AND THAT MOST OF THIS CELL DEATH IS


APOPTOTIC6. MODIFIED PEPTIDES, SUCH AS ACETYL–TYROSINYL–VALYL–ALANYL–ASPARTYL–CHLORO– METHYLKETONE (AC–YVAD–CMK), THAT SPECIFICALLY INHIBIT PROTEASES OF THE CASPASE FAMILY7 EFFECTIVELY BLOCK


APOPTOSIS IN A PLETHORA OF EXPERIMENTAL PARADIGMS, SUCH AS GROWTH FACTOR WITHDRAWAL8, EXCITOTOXICITY9, AXOTOMY10, CEREBRAL ISCHEMIA11 AND BRAIN TRAUMA12. HERE WE EXAMINED THE EFFECTS OF


CASPASE INHIBITION BY AC–YVAD–CMK ON CELL DEATH IMMEDIATELY AFTER DONOR TISSUE PREPARATION AND ON LONG–TERM GRAFT SURVIVAL. TREATMENT OF THE EMBRYONIC NIGRAL CELL SUSPENSION WITH AC–YVAD–CMK


MITIGATED DNA FRAGMENTATION AND REDUCED APOPTOSIS IN TRANSPLANTS. IT ALSO INCREASED SURVIVAL OF DOPAMINERGIC NEURONS GRAFTED TO HEMIPARKINSONIAN RATS, AND THEREBY SUBSTANTIALLY IMPROVED


FUNCTIONAL RECOVERY. Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution


Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full


article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs *


Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS MITOCHONDRIA TRANSPLANTATION TRANSIENTLY RESCUES CEREBELLAR NEURODEGENERATION IMPROVING MITOCHONDRIAL FUNCTION AND REDUCING


MITOPHAGY IN MICE Article Open access 22 March 2025 HUMAN STEM CELLS HARBORING A SUICIDE GENE IMPROVE THE SAFETY AND STANDARDISATION OF NEURAL TRANSPLANTS IN PARKINSONIAN RATS Article Open


access 27 May 2021 OPTIMIZING MATURITY AND DOSE OF IPSC-DERIVED DOPAMINE PROGENITOR CELL THERAPY FOR PARKINSON’S DISEASE Article Open access 21 April 2022 REFERENCES * Lindvall, O. Neural


transplantation: a hope for patients with Parkinson's disease. _ Neuroreport_ 8, III–X ( 1997). Article  CAS  Google Scholar  * Olanow, C.W., Kordower, J.H. & Freeman, T.B. Fetal


nigral transplantation as a therapy for Parkinson's disease. _Trends Neurosci._ 19, 102– 109 (1996). Article  CAS  Google Scholar  * Kordower, J.H. _ et al._ Functional fetal nigral


grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies. _ J. Comp. Neurol._ 24, 203–230 (1996). Article  Google Scholar  * Kordower J.H. _


et al._ Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease. _Mov. Disord._ 13 , 383–393 (1998). Article  CAS  Google Scholar  * Barker, R.A.,


Dunnett, S.B., Faissner, A. & Fawcett, J.W. The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum. _Exp.


Neurol. _ 141, 79–93 ( 1996). Article  CAS  Google Scholar  * Zawada, W.M. _ et al._ Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats.


_Brain Res._ 786, 96–103 (1998). Article  CAS  Google Scholar  * Villa, P., Kaufmann, S.H. & Earnshaw, W.C. Caspases and caspase inhibitors. _Trends Biochem. Sci._ 22, 388–393 (1997).


Article  CAS  Google Scholar  * Milligan, C.E. _ et al._ Peptide inhibitors of the ICE protease family arrest programmed cell death of motoneurons _in vivo_ and _in vitro_. _ Neuron_ 15,


385–393 ( 1995). Article  CAS  Google Scholar  * Leist, M. _et al._ Caspase–mediated apoptosis in neuronal excitotoxicity triggered by nitric oxide. _Mol. Med._ 3, 750– 764 (1997). Article 


CAS  Google Scholar  * de Bilbao, F. & Dubois–Dauphin, M. Acute application of an interleukin–1 beta–converting enzyme–specific inhibitor delays axotomy–induced motoneurone death.


_Neuroreport_ 25, 3051–3054 (1996). Article  Google Scholar  * Hara, H. _et al._ Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal


damage. _Proc. Natl. Acad. Sci. USA_ 94, 2007–2012 ( 1997). Article  CAS  Google Scholar  * Yakovlev, A.G. _ et al._ Activation of CPP32–like caspases contributes to neuronal apoptosis and


neurological dysfunction after traumatic brain injury. _ J. Neurosci._ 17, 7415–7424 (1997). Article  CAS  Google Scholar  * Leist, M., Single, B., Castoldi, A.F., Kuhnle, S. & Nicotera,


P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. _J. Exp. Med._ 185, 1481– 1486 (1997). Article  CAS  Google Scholar  *


Mahalik, T.J., Hahn, W.E., Clayton, G.H. & Owens, G.P. Programmed cell death in developing grafts of fetal substantia nigra. _ Exp. Neurol._ 129, 27–36 (1994). Article  CAS  Google


Scholar  * Nakao, N., Frodl, E.M., Duan, W.–M., Widner, H. & Brundin, P. Lazaroids improve the survival of grafted rat embryonic dopamine neurons. _Proc. Natl. Acad. Sci. USA_ 91,


12408–12412 ( 1994). Article  CAS  Google Scholar  * Green, D. & Kroemer, G. The central executioners of apoptosis: caspases or mitochondria? _Trends Cell Biol._ 8, 267–271 (1998).


Article  CAS  Google Scholar  * Leist, M. & Nicotera, P. Apoptosis, excitotoxicity, and neuropathology. _Exp. Cell Res._ 239, 183– 201 (1998). Article  CAS  Google Scholar  * Nakao, N.


_et al._ Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease. _Nature Med._ 1, 226–231 ( 1995). Article  CAS 


Google Scholar  * Rosenblad, C., Martinez–Serrano, A. & Björklund, A. Glial cell line–derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral


dopaminergic grafts. _Neuroscience_ 75, 979 –985 (1996). Article  CAS  Google Scholar  * Mayer, E., Fawcett, J.W. & Dunnett, S.B. Basic fibroblast growth factor promotes the survival of


embryonic ventral mesencephalic dopaminergic neurons—II. Effects on nigral transplants _in vivo_. _Neuroscience_ 56, 389–98 (1993). Article  CAS  Google Scholar  * Karlsson, J., Emgård, M.,


Rosenblad, C. & Brundin, P. Treatment with the spin–trap agent α–phenyl–N–tert–butyl nitrone does not enhance the survival of embryonic or adult dopamine neurons. _Brain Res_. 805,


155–168 (1998). Article  CAS  Google Scholar  * Whiteside, G., Cougnon, N., Hunt, S.P. & Munglani, R. An improved method for detection of apoptosis in tissue sections and cell culture,


using the TUNEL technique combined with Hoechst stain. _Brain Res. Brain Res. Protoc._ 2, 160–164 ( 1998). Article  CAS  Google Scholar  * Duan, W.–M., Widner, H., Cameron, R.M. &


Brundin, P. Quinolinic acid–induced inflammation in the striatum does not impair the survival of neural allografts in the rat. _Eur. J. Neurosci _ . 10, 2595–2606 ( 1998). Article  CAS 


Google Scholar  * West, M.J., Slomianka, L. & Gundersen, H.J. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the


optical fractionator. _Anat. Rec._ 231, 482–497 (1991). Article  CAS  Google Scholar  Download references ACKNOWLEDGEMENTS _We acknowledge the technical assistance of T. Björklund, B.


Haraldsson, H. Naumann, B. Lindberg and M. Pettersson. This study was supported by grants from the Medical Faculty at Lund University, the Swedish Medical Research Council, the Thorsten and


Elsa Segerfalk Foundation, and Deutsche Forschungsgemeinschaft. G.S.S. was supported by a Marie Curie Fellowship within the 4th framework program of the European Commission._ AUTHOR


INFORMATION AUTHORS AND AFFILIATIONS * Section for Neuronal Survival, Wallenberg Neuroscience Center, Lund University, Sölvegatan 17, Lund, S–223 62, Sweden Gabriele S. Schierle, Oskar


Hansson, Håkan Widner & Patrik Brundin * Chair of Molecular Toxicology, Faculty of Biology, Konstanz University, Box X911, Konstanz, D–78457, Germany Marcel Leist & Pierluigi


Nicotera Authors * Gabriele S. Schierle View author publications You can also search for this author inPubMed Google Scholar * Oskar Hansson View author publications You can also search for


this author inPubMed Google Scholar * Marcel Leist View author publications You can also search for this author inPubMed Google Scholar * Pierluigi Nicotera View author publications You can


also search for this author inPubMed Google Scholar * Håkan Widner View author publications You can also search for this author inPubMed Google Scholar * Patrik Brundin View author


publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to Gabriele S. Schierle. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT


THIS ARTICLE CITE THIS ARTICLE Schierle, G., Hansson, O., Leist, M. _et al._ Caspase inhibition reduces apoptosis and increases survival of nigral transplants. _Nat Med_ 5, 97–100 (1999).


https://doi.org/10.1038/4785 Download citation * Received: 16 August 1998 * Accepted: 23 November 1998 * Issue Date: January 1999 * DOI: https://doi.org/10.1038/4785 SHARE THIS ARTICLE


Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided


by the Springer Nature SharedIt content-sharing initiative